HOB Biotech Group Corp

HOB Biotech Group Corp Inventory

The Inventory of HOB Biotech Group Corp (688656.SS) as of Nov 5, 2026 is 107.08 M CNY. In the previous year, Inventory was 111.22 M CNY — a change of -3.72% (lower).

Inventory

107.08 MCNY

YoY

-3.72%

Last updated:

Inventory of HOB Biotech Group Corp is 2025 107.08 M CNY. Inventory of HOB Biotech Group Corp was 2024 111.22 M CNY. It decreases by -3.72% lower compared to the previous year.

The HOB Biotech Group Corp Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2018
49.16 M CNY
Jan 1, 2019
59.63 M CNY
Jan 1, 2020
61.95 M CNY
Jan 1, 2021
68.20 M CNY
Jan 1, 2022
87.80 M CNY
Jan 1, 2023
111.22 M CNY
Jan 1, 2024
111.22 M CNY
Jan 1, 2025
107.08 M CNY
The HOB Biotech Group Corp Inventory history
YEARInventoryYoY
107.08 MCNY-3.72%
111.22 MCNY+0.00%
111.22 MCNY+26.67%
87.80 MCNY+28.73%
68.20 MCNY+10.10%
61.95 MCNY+3.88%
59.63 MCNY+21.30%
49.16 MCNY+26.92%
38.73 MCNY+29.06%
30.01 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

HOB Biotech Group Corp Stock analysis

What does HOB Biotech Group Corp do? HOB Biotech Group Corp Ltd generates revenue through the research, development, production, and sale of in-vitro diagnostic reagents, primarily targeting domestic markets. The company offers allergy testing products under brands Oboke, Fubok, Shibok, and Shibok Plus, utilizing qualitative detection techniques like enzyme-linked immunosorbent assay. Self-immune testing products are sold under Norbok and Nabok, employing quantitative methods such as enzyme-linked immunoassay capture and nano-magnetic particle chemiluminescence. Additional income comes from reagent supporting testing instruments and related services. The domestic market serves as the primary customer segment for HOB Biotech's products, with healthcare providers and laboratories purchasing allergy and self-immune testing solutions. Allergy testing brands Oboke, Fubok, Shibok, and Shibok Plus cater to qualitative detection needs, while Norbok and Nabok address quantitative detection requirements for self-immune testing. The company's product portfolio is structured around these distinct brand categories and detection techniques. HOB Biotech's revenue streams are derived from the sale of branded diagnostic reagents and supporting instruments, with no mention of external partnerships or international markets. The firm focuses exclusively on domestic sales, leveraging its two product categories and five distinct brands to serve healthcare institutions requiring in-vitro diagnostic solutions. HOB Biotech Group Corp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about HOB Biotech Group Corp stock

Inventory of HOB Biotech Group Corp is 107.08 M CNY in 2025.

Inventory of HOB Biotech Group Corp changed from 111.22 M CNY to 107.08 M CNY, representing a -3.72% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Inventory HOB Biotech Group Corp since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's HOB Biotech Group Corp historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — HOB Biotech Group Corp

All Key Metrics — HOB Biotech Group Corp